(Q47896134)

6 February 2018

title

Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assay (English)

1 reference

6 February 2018

1 reference

1 reference

H De Witte

1

1 reference

6 February 2018

F Sweep

2

1 reference

6 February 2018

N Brünner

3

1 reference

6 February 2018

J Heuvel

4

1 reference

6 February 2018

L Beex

5

1 reference

6 February 2018

N Grebenschikov

6

1 reference

6 February 2018

T Benraad

7

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 February 2018

International Journal of Cancer

published in

1 reference

6 February 2018

volume

77

1 reference

6 February 2018

issue

2

1 reference

6 February 2018

page(s)

236-242

1 reference

6 February 2018

The urokinase-type plasminogen activator system in cancer metastasis: a review

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

High-affinity urokinase receptor antagonists identified with bacteriophage peptide display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Monoclonal antibody that specifically inhibits a human Mr 52,000 plasminogen-activating enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

A better cell line for making hybridomas secreting specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Quantitation of urokinase antigen in plasma and culture media by use of an ELISA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and of plasminogen activator inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Ligand interaction between urokinase-type plasminogen activator and its receptor probed with 8-anilino-1-naphthalenesulfonate. Evidence for a hydrophobic binding site exposed only on the intact receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819980717%2977%3A2%3C236%3A%3AAID-IJC12%3E3.0.CO%3B2-9

10.1002/(SICI)1097-0215(19980717)77:2<236::AID-IJC12>3.0.CO;2-9

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018